Title : Inhibition by rapamycin of P-glycoprotein 170-mediated export from normal lymphocytes.

Pub. Date : 1996 Apr

PMID : 8668925






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rapamycin was compared to cyclosporine A for its ability to inhibit P-glycoprotein on normal human peripheral blood mononuclear cells (PBMC). Sirolimus ATP binding cassette subfamily B member 1 Homo sapiens
2 P-glycoprotein inhibition of ex vivo lymphocytes with three multi-drug resistant T-cell lines showed susceptibility of P-glycoprotein to rapamycin dependent on the cell type. Sirolimus ATP binding cassette subfamily B member 1 Homo sapiens
3 P-glycoprotein inhibition of ex vivo lymphocytes with three multi-drug resistant T-cell lines showed susceptibility of P-glycoprotein to rapamycin dependent on the cell type. Sirolimus ATP binding cassette subfamily B member 1 Homo sapiens
4 Compared to cyclosporine A, the reduced ability of rapamycin to inhibit P-glycoprotein reflects a reduced avidity in its binding to P-glycoprotein and perhaps increased access to the cell interior. Sirolimus ATP binding cassette subfamily B member 1 Homo sapiens
5 Compared to cyclosporine A, the reduced ability of rapamycin to inhibit P-glycoprotein reflects a reduced avidity in its binding to P-glycoprotein and perhaps increased access to the cell interior. Sirolimus ATP binding cassette subfamily B member 1 Homo sapiens
6 The authors speculate that interactions with P-glycoprotein may partially modulate the immunosuppressive effects of rapamycin. Sirolimus ATP binding cassette subfamily B member 1 Homo sapiens